1Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med, 2013:39 - 44.
2Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microe- mbolisation. Lancet Neurol, 2010, 9:309 - 317.
3Viola S, Viola P, Litterio P, et d. Stroke risk and migra- ine: near-infrared spectroscopy study. Neurol Sci, 2012, 33:173 - 175.
4Arulmani U, Gupta S, VanDenBrink AM, et al. Experi- mental migraine models and their relevance in migraine therapy. Cephalalgia, 2006, 26:642 - 659.
5Gupta S, Villal6n CM. The relevance of preclinicalresearch models for the development of antimigraine drugs: Focus on 5-HT 1B/1D and CGRP receptors. Pharmacol Ther, 2010, 128:170 - 190.
6Buzzi MG, Tassorelli C. Experimental models of migr- aine. Handb Clin Neurol, 2010, 97:109 - 123.
7Bohr Z, Fejes-Szab6 A, Tar L, et al. Evaluation ofc-Fos immunoreactivity in the rat brainstem nuclei relevant in migraine pathogenesis after electrical stimulation of the trigeminal ganglion. Neurol Sci. 2013; 34:1597 - 1604.
8Ramirez Rosas MB, Labruijere S, Villal6n CM, et al. Activation of 5-hydroxytryptaminelB/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opin Pharmacother, 2013, 14:1599 - 1610.
10Wang X, Fang Y, Liang J, et al. Selective Inhibition of 5-HT7 Receptor Reduces CGRP Release in an Experimental Model for Migraine. Headache, 2010, 50:579 - 587.
4Sagasta A,Molina-Urra R,Martinez D,et al.Cd8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma.J cutaneous,2014,12(5):97-102.
5Eftekhari S,Warfvinge K,W Blixt F,et al.Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system.The journal of pain:official journal of the American Pain Society,2013,14(11):1289-1303.
6Laursen JC,Cairns BE,Kumar U,et al.Nitric oxide release from trigeminal satellite glial cells is attenuated by glial modulators and glutamate.International journal physiology,pathophy pharm,2013,5(4):228-238.
7J an s en-O les en I,B au n M,A mr u tk ar D V,et al.PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.Neuropeptides,2014,48(2):53-64.
8Watts SW.Serotonin and sensory nerves:Meeting in the cardiovascular system.Vascular pharmacol,2014;63(1):1-3.
9Vollbracht S,Rapoport AM.The pipeline in headache therapy.CNS drugs,2013,27(9):717-729.
